Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Chyenne D, Yeager"'
Autor:
Hamza Ijaz, Frank R. Urena, Des White, Chyenne D. Yeager, David J. Mooney, Vasanth Chandrasekhar, Alexander G. Stafford, Justin M. Scott, Benjamin T. Seiler, Amanda R. Graveline, Edward J. Doherty, Fernanda Langellotto, Mark Cartwright, Shanda L. Lightbown, Aileen W. Li, Caitlin L. Horgan, Mohan Karkada, Donald E. Ingber, Collin Leese-Thompson, Michael Super, Sami A. Rifai, Maxence O. Dellacherie, Nikolaos Dimitrakakis, Kayla R. Lightbown, Amanda R. Jiang
Publikováno v:
Nature Biomedical Engineering. 6:8-18
Most bacterial vaccines work for a subset of bacterial strains or require the modification of the antigen or isolation of the pathogen before vaccine development. Here we report injectable biomaterial vaccines that trigger potent humoral and T-cell r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::10f25a46b11b58f1a23c029f6b1447a5
https://doi.org/10.1038/s41551-021-00756-3
https://doi.org/10.1038/s41551-021-00756-3
Autor:
Alexander J. Najibi, Maxence O. Dellacherie, Ting‐Yu Shih, Edward J. Doherty, Des A. White, Tomás Bauleth‐Ramos, Alexander G. Stafford, James C. Weaver, Chyenne D. Yeager, Benjamin T. Seiler, Matthew Pezone, Aileen W. Li, Bruno Sarmento, Hélder A. Santos, David J. Mooney, Luo Gu
Publikováno v:
Advanced Functional Materials, 32:2110905. WILEY-V C H VERLAG GMBH
Traditional bolus vaccines often fail to sustain robust adaptive immune responses, typically requiring multiple booster shots for optimal efficacy. Additionally, these provide few opportunities to control the resulting subclasses of antibodies produc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a7f37301590bad08754a30b13ae4b0e
https://research.rug.nl/en/publications/a8fe6c37-fe4a-4f6d-81e6-d5fff085ecb2
https://research.rug.nl/en/publications/a8fe6c37-fe4a-4f6d-81e6-d5fff085ecb2
Autor:
Maxence O. Dellacherie, Sarai Bardales, David J. Mooney, Benjamin T. Seiler, Christina M. Tringides, Hamza Ijaz, Anna N. Honko, Makda S. Gebre, Rebecca I. Johnson, Anthony Griffiths, Tal Gilboa, Jingyou Yu, Dan H. Barouch, Chi-An Cheng, Des White, Mark Cartwright, Edward J. Doherty, Nikolaos Dimitrakakis, Amanda R. Graveline, Fernanda Langellotto, Nadia Storm, David R. Walt, Chyenne D. Yeager
Publikováno v:
Advanced Healthcare Materials
The coronavirus disease 2019 (COVID‐19) pandemic demonstrates the importance of generating safe and efficacious vaccines that can be rapidly deployed against emerging pathogens. Subunit vaccines are considered among the safest, but proteins used in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::66cadaaf0d95bf66a32f4d1a698ddfe9
http://europepmc.org/articles/PMC8652677
http://europepmc.org/articles/PMC8652677
Autor:
Benjamin T. Seiler, Des White, Mark Cartwright, Chyenne D. Yeager, Fernanda Langellotto, Jingyou Yu, Michael Super, Dan H. Barouch, Edward J. Doherty, David J. Mooney
The global COVID-19 pandemic motivates accelerated research to develop safe and efficacious vaccines. To address this need, we leveraged a biomaterial vaccine technology that consists of mesoporous silica rods (MSRs) that provide a sustained release
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c98329d0564044411145a704a50e7385
https://doi.org/10.1101/2020.07.07.192203
https://doi.org/10.1101/2020.07.07.192203
Autor:
Michael, Super, Edward J, Doherty, Mark J, Cartwright, Benjamin T, Seiler, Fernanda, Langellotto, Nikolaos, Dimitrakakis, Des A, White, Alexander G, Stafford, Mohan, Karkada, Amanda R, Graveline, Caitlin L, Horgan, Kayla R, Lightbown, Frank R, Urena, Chyenne D, Yeager, Sami A, Rifai, Maxence O, Dellacherie, Aileen W, Li, Collin, Leese-Thompson, Hamza, Ijaz, Amanda R, Jiang, Vasanth, Chandrasekhar, Justin M, Scott, Shanda L, Lightbown, Donald E, Ingber, David J, Mooney
Publikováno v:
Nature biomedical engineering. 6(1)
Most bacterial vaccines work for a subset of bacterial strains or require the modification of the antigen or isolation of the pathogen before vaccine development. Here we report injectable biomaterial vaccines that trigger potent humoral and T-cell r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::bc946ad2dc3778000c271485729c4614
https://pubmed.ncbi.nlm.nih.gov/34239117
https://pubmed.ncbi.nlm.nih.gov/34239117
Autor:
Fernanda Langellotto, Des White, Chyenne D. Yeager, Frank R. Urena, Caitlin L. Horgan, Alexander G. Stafford, David J. Mooney, Edward J. Doherty, Justin M. Scott, Benjamin T. Seiler, Sami A. Rifai, Mark Cartwright, Nikolaos Dimitrakakis, Shanda L. Lightbown, Vasanth Chandrasekhar, Michael Super, Kayla R. Lightbown, Aileen W. Li, Donald E. Ingber, Amanda R. Graveline, Maxence O. Dellacherie, Mohan Karkada, Amanda R. Jiang
Broad spectrum vaccines could provide a solution to the emergence of antibiotic resistant microbes, pandemics and engineered biothreat agents. Here, we describe a modular vaccine (composite infection vaccine technology (ciVAX)) which can be rapidly a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c5e73d1cc6b33576b6372137cb721f60
https://doi.org/10.1101/2020.02.25.964601
https://doi.org/10.1101/2020.02.25.964601